Entropy Technologies LP Buys Shares of 88,939 Healthpeak Properties, Inc. (NYSE:DOC)

Entropy Technologies LP purchased a new position in Healthpeak Properties, Inc. (NYSE:DOCFree Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 88,939 shares of the real estate investment trust’s stock, valued at approximately $2,034,000.

Several other hedge funds also recently made changes to their positions in DOC. abrdn plc bought a new position in Healthpeak Properties in the 3rd quarter worth about $62,670,000. Douglas Lane & Associates LLC bought a new position in shares of Healthpeak Properties in the third quarter valued at approximately $33,947,000. Foresight Group Ltd Liability Partnership bought a new position in shares of Healthpeak Properties in the third quarter valued at approximately $33,212,000. Asset Management One Co. Ltd. purchased a new position in Healthpeak Properties during the third quarter valued at approximately $29,934,000. Finally, Raymond James & Associates bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $25,711,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Down 2.6 %

DOC opened at $21.77 on Wednesday. The company has a market cap of $15.23 billion, a P/E ratio of 47.00, a P/E/G ratio of 2.54 and a beta of 1.13. Healthpeak Properties, Inc. has a 12 month low of $15.44 and a 12 month high of $23.26. The business’s 50-day moving average price is $22.32 and its 200-day moving average price is $21.00. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93.

Healthpeak Properties (NYSE:DOCGet Free Report) last announced its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.32). Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The company had revenue of $700.40 million during the quarter, compared to the consensus estimate of $682.51 million. During the same quarter in the previous year, the firm posted $0.45 EPS. The business’s revenue for the quarter was up 25.9% compared to the same quarter last year. On average, equities analysts expect that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.51%. The ex-dividend date of this dividend is Monday, November 4th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 255.32%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on DOC shares. Robert W. Baird raised their price target on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Scotiabank boosted their target price on Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research report on Monday, September 9th. Royal Bank of Canada raised their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Wells Fargo & Company reissued an “equal weight” rating and set a $23.00 price objective (up previously from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st. Finally, Evercore ISI raised their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, September 16th. One analyst has rated the stock with a sell rating, five have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $22.86.

Get Our Latest Analysis on DOC

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

See Also

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.